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GETTING TO THE GOOD PLACE: IMPLEMENTING NEW JERSEY’S 
MEDICAL AID IN DYING FOR THE TERMINALLY ILL ACT 
Megan Nigro* 
I.  INTRODUCTION 
In 2019, New Jersey approved an aid in dying bill and joined several 
states that have expanded legal end of life choices to include forms of 
physician-assisted death.  New Jersey’s Medical Aid in Dying for the 
Terminally Ill Act (hereinafter “the Act”) raises interesting questions 
about patient choice, but some patients have not been able to use this 
choice since the Act became effective on August 1, 2019.  Robin Granat, 
a former singer and ice skater, diagnosed with an incurable brain tumor, 
made an appointment for August 19, 2019, to make her first request for 
the aid in dying medication.1  Before the appointment, a Mercer County 
court had already placed a temporary restraining order on the Act.2  A 
few days later, Robin lost her ability to speak and could not make her 
first oral request as required by the Act.3  Other New Jersey patients 
have used or still hope to use the Act.  Katie Kim, a former pharmacist, 
diagnosed with an incurable neuromuscular disorder eight years prior, 
wanted to move to a state with an aid in dying law, but her doctors were 
 
*J.D. Candidate, 2021, Seton Hall University School of Law; B.A., 2018, Wake Forest 
University.  Many thanks to Professor Carl Coleman for his guidance and to Tracy 
Forsyth, Deputy General Counsel at University Hospital, for her support in pursuing this 
topic.  
 1 Lindy Washburn & Stacey Barchenger, She Hoped for Death on Her Own Terms. 




 2 Id.  The temporary injunction on the use of the Act had been removed, but the 
lawsuit continued.  Stacey Barchenger, New Jersey’s ‘Aid-in-Dying’ Law Reinstated After 
a Pair of Court Rulings, TRENTON BUREAU (Aug. 27, 2019, 10:53 AM), https://www.north
jersey.com/story/news/2019/08/27/nj-aid-dying-law-reinstated-appeals-court/212
9382001.  The doctor suing argued that the Act as a whole was unconstitutional, and he 
objected to turning over patient records in compliance with the Act.  Id.  In 2020, the 
judge dismissed the case for “failure to state a claim upon which relief may be granted.”  
Glassman v. Grewal, No. MER-C-53-19 (N.J. Super. Ct. Ch. Div. Apr. 1, 2020) (order 
granting dismissal of complaint). 
 3 Washburn & Barchenger, supra note 1. 
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all in New Jersey.4  When New Jersey allowed a similar choice, she hoped 
to use the law to help her die in peace.5  Within the first several weeks 
of the Act, at least one New Jersey resident used the Act to request and 
self-administer medication to end her suffering.6  Zebbie Geller, a retired 
teacher, was diagnosed with terminal lung cancer nine months prior 
and was told she had only months left to live.7  From July 2019 to her 
death at the end of September 2019, Zebbie and her family contacted 40 
doctors before they could find physicians willing to aid in Zebbie’s 
death.8  At eighty-years-old and while surrounded by family, Zebbie 
swallowed an anti-nausea pill and apple juice mixed with digoxin, “a 
cardiac drug that slows the heart,” and died within 90 minutes.9  
Zebbie’s story depicts how the Act was made to work.  Zebbie met the 
standard requirements, physicians could personally object to aid in her 
dying, and Zebbie could request and self-administer her own 
medication.10   
This Comment discusses considerations for implementation for 
New Jersey doctors and facilities on behalf of New Jersey patients who 
want to participate in successful aid in dying stories like Zebbie’s.  As 
readers consider this Comment, they should think about these patients 
and the myriad of other patients who might choose to request or use aid 
in dying medication.  This Comment will not discuss whether New Jersey 
patients should have the right to make this choice.  This Comment will 
examine other states and countries where patients have similar end of 
life options and make suggestions for New Jersey safeguards and best 
practices so the Act may best serve its purpose in providing patients 
with this end of life choice and protecting against unintended 
consequences and abuse. 
While the Act does promise to give patients more choice while 
protecting them from coercion, abuse, or neglect, and is partially 
modeled after statutes in other states, this Comment argues that New 
Jersey can learn from other states and countries in its implementation 
 
 4 Susan K. Livio, She Wants to End Her Life Because of Agonizing Pain. ‘Every Day 
Katie Asks Me to Help Her Die.’, N.J. ADVANCE MEDIA (Aug. 23, 2019), https://www.nj.com/
news/2019/08/she-wants-to-die-because-of-agonizing-pain-from-incurable-disease-
but-law-that-gave-hope-is-stalled.html. 
 5 Id. 
 6 Susan K. Livio, N.J. Woman Used New Law to End Her Life. ‘I’m Ready, Let’s Do It.’, N.J. 
ADVANCE MEDIA (Oct. 18, 2019), https://www.nj.com/news/2019/10/nj-woman-used-
new-law-to-end-her-life-im-ready-lets-do-it.html. 
 7 Id. 
 8 Id. 
 9 See id. 
 10 See id. 
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and application while considering its unique population and statutory 
definitions.  Part II introduces the Act and the statutory language 
describing the self-administration, residency, and time between 
requests requirements and discusses initial concerns with the 
definitions and language.  Part III analyzes and compares other states’ 
and countries’ definitions of the three requirements discussed in this 
Comment, with an emphasis on the self-administration requirement.  
Part IV compares usage and implementation based on a statistical 
analysis of census data and state aid in dying reports.  Part V converts 
these comparisons into considerations for New Jersey’s implementation 
and best practices. 
II.  DEFINITIONS IN NEW JERSEY’S MEDICAL AID IN DYING FOR THE TERMINALLY 
ILL ACT 
This Part introduces New Jersey’s Medical Aid in Dying for the 
Terminally Ill Act and explains three definitions from the Act: self-
administer, resident, and time between requests. 
A.  Introduction to the Act 
In April 2019, after seven years of proposed legislation,11 Governor 
Murphy signed New Jersey’s Medical Aid in Dying for the Terminally Ill 
Act.12  While Governor Murphy grappled with the ethical questions 
raised by this legislation, he ultimately wanted New Jersey residents to 
have the freedom to make their own end of life choices.13  The Act itself 
states its purpose to continue the state’s “long-standing commitment to 
individual dignity, informed consent, and the fundamental right of 
competent adults to make health care decisions.”14 
Under the Act, only specific adults will be eligible to make aid in 
dying their end of life choice.15  The Act defines a qualified terminally ill 
patient as follows: 
[A] capable adult who is a resident of New Jersey and has 
satisfied the requirements to obtain a prescription for 
medication pursuant to P.L.2019, c.59 (C.26:16-1 et al.). A 
 
 11 To read more about the years of legislation, see New Jersey, COMPASSION & CHOICES, 
https://compassionandchoices.org/in-your-state/new-jersey/#extended-state-
content (last visited Oct. 29, 2019). 
 12 Philip D. Murphy, Governor’s Statement Upon Signing Assembly Bill No. 1504 (Apr. 
12, 2019), http://d31hzlhk6di2h5.cloudfront.net/20190412/4b/cd/8b/1f/02854e1f1
393a35250679633/A1504.pdf. 
 13 Id. 
 14 N.J. STAT. ANN. § 26:16-2 (2019), https://www.njleg.state.nj.us/2018/Bills/PL19/
59_.PDF. 
 15 § 26:16-1 to 20. 
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person shall not be considered to be a qualified terminally ill 
patient solely because of the person’s age or disability or a 
diagnosis of any specific illness, disease, or condition.16 
Furthermore, “‘[t]erminally ill’ means that the patient is in the terminal 
stage of an irreversibly fatal illness, disease, or condition with a 
prognosis, based upon reasonable medical certainty, of a life expectancy 
of six months or less.”17  A qualified patient must make three requests 
before an attending physician can prescribe aid in dying medication.18  
The Act provides a sample written request form for patients to use as 
one of the three requests.19  The attending physician must also refer the 
qualified patient to a consulting physician who may confirm the physical 
diagnosis and the patient’s capability to make an informed and 
voluntary decision.20  If either physician has questions or concerns 
about a patient’s mental capability, that physician must refer the patient 
to a mental health care professional.21  The Act clarifies twice that any 
health care professional or patient who takes action under the Act does 
not participate in euthanasia, suicide, assisted suicide, or homicide.22  
Therefore, this Comment respectfully refers to the actions taken under 
the Act as furthering aid in dying but uses other states’ and countries’ 
respective terms, such as euthanasia, when discussing those 
jurisdictions’ laws. 
B.  Defining and Applying Self-Administration 
In New Jersey’s statute, “‘[s]elf-administer’ means a qualified 
terminally ill patient’s act of physically administering, to the patient’s 
own self, medication that has been prescribed pursuant to” the Act.23  
This language impliedly excludes any patient who may otherwise 
qualify for the Act but lacks enough physical strength or coordination to 
administer their own medication.  This may include patients who had an 
existing physical disability limiting strength or coordination before 
acquiring a terminal illness and becoming otherwise eligible for the Act.  
The Act could also exclude a patient who, through the time it takes to 
complete the Act’s requirements, loses her strength and ability to self-
administer medication.  Remember that Zebbie Geller needed enough 
 
 16 § 26:16-3. 
 17 Id. 
 18 § 26:16-10. 
 19 § 26:16. 
 20 § 26:16-6. 
 21 § 26:16-8. 
 22 § 26:16-15, -17. 
 23 § 26:16-3. 
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control of her limbs and head to take a pill and drink a medication.24  The 
Act, however, does not explicitly state that a patient must ingest (rather 
than inject) medication, but the requirements discussed herein imply an 
expectation that a patient would have the physical ability to ingest the 
medication. 
Further analysis of the Act demonstrates how the term “self-
administer” imposes certain physical eligibility requirements for 
patients beginning with the first request.  A patient must complete a 
valid written request for the aid in dying medication.25  A valid written 
request must be initialed, signed, and dated by the patient.26  The Act 
requires a patient to have enough physical strength and coordination to 
initial, sign, and date a document.  The same hypothetical patient 
discussed above, who had a physical disability before terminal illness or 
who acquired a physical disability since diagnosis of a terminal illness, 
could be excluded even before consideration of whether that patient can 
physically self-administer if that patient physically cannot complete the 
required written request. 
C.  Defining and Applying Residency 
Under the Act, the attending physician who would ultimately 
prescribe the aid in dying medication must require the patient to 
demonstrate New Jersey residency.27  The patient must provide the 
physician with a copy of: 
a. a driver’s license or non-driver identification card issued by 
the New Jersey Motor Vehicle Commission;  
b. proof that the person is registered to vote in New Jersey;  
c. a New Jersey resident gross income tax return filed for the 
most recent tax year; or  
d. any other government record that the attending physician 
reasonably believes to demonstrate the individual’s current 
residency in this State.28 
This language allows for a person who previously lived in New 
Jersey but currently resides across the accessible borders of New York 
or Pennsylvania to continue to utilize a New Jersey driver’s license to 
easily access the Act.  In becoming a terminally ill patient, a person could 
utilize a license with her hometown address to access the Act while 
residing in New York City.  Patients with terminal illnesses may not have 
 
 24 See Livio, supra note 6. 
 25 § 26:16-5. 
 26 § 26:16-20. 
 27 § 26:16-6. 
 28 § 26:16-11. 
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the strength or ability to change states.29  But an inability to travel 
because of a need for particular doctors or lack of strength may be made 
easier by the physical proximity of New Jersey’s neighboring states.  Part 
(d) of the residency definition leaves room for physician discretion in 
determining residency.30  As applied by an attending physician, this 
discretionary portion could work either in favor of or against patient 
access to aid in dying medication.  A physician could reasonably find 
residency in (d) even when a patient may not be a New Jersey resident.  
A patient who is a resident of New Jersey may only have (d) 
documentation but be denied legitimate access to the Act because of the 
physician’s discretionary determination of residency.  While physicians 
are always allowed to refuse to participate in aid in dying,31 patients 
without an ID, voter registration, or a most recent tax return might feel 
a sense of injustice if their request is denied for lack of such 
documentation.  Residency seems like it should be a simple checkmark 
in the Act’s requirements, but entire court cases can dispute a person’s 
residency in one or multiple locations.32 
D.  Defining and Applying Time Between Requests  
Under the Act, patients and physicians must follow a minimum 
timeline for making requests and writing prescriptions.33  The timeline 
requires that: 
(1) at least 15 days shall elapse between the initial oral 
request and the second oral request; . . . 
(3) the patient may submit the written request to the 
attending physician when the patient makes the initial oral 
request or at any time thereafter; . . . 
(5) at least 15 days shall elapse between the patient’s initial 
oral request and the writing of a prescription pursuant to 
P.L.2019, c.59 (C.26:16-1 et al.); and  
(6) at least 48 hours shall elapse between the attending 
physician’s receipt of the patient’s written request and the 
writing of a prescription . . . .34 
In applying the quickest scenario possible, a patient could submit an oral 
and written request on Day One, wait fifteen days, submit a second oral 
request on Day Sixteen, and receive a prescription to self-administer the 
 
 29 See, e.g., Livio, supra note 4. 
 30 § 26:16-11. 
 31 See § 26:16-3. 
 32 See generally Sheehan v. Gustafson, 967 F.2d 1214 (8th Cir. 1992). 
 33 § 26:16-10. 
 34 Id.  
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same day.35  But if a patient waits until his second oral request on Day 
Sixteen to provide a written request, then the attending physician must 
wait until at least Day Eighteen to write the prescription.36  A clear 
reading of the Act does not impose a maximum time limit between 
patient requests.  A qualified terminally ill patient could make an initial 
request in January 2021, survive past a six-month prognosis, and make 
the second oral request with a written request in January 2022.  Under 
the Act, the patient has not re-started the aid in dying process.  
Additionally, the Act does not set a maximum amount of time between 
an attending physician receiving oral and written requests and writing 
a prescription for medication.37 
The lack of maximum time between requests will become an issue 
when trying to evaluate the efficiency of implementation under the Act.  
While attending physicians are required to document all requests,38 an 
attending physician is only required to report the dispensing 
medication record and the death record to the Department of Health for 
statistical purposes.39  Therefore, the public data of the Act will only 
show two points in the aid in dying process; thus, limiting New Jersey’s 
understanding of average time spent considering and completing this 
end of life option.  If a purpose of the Act is to increase patient choice in 
treatment, then New Jersey should understand the length of time a 
patient takes to make and implement treatment choices. 
III.  IMPLEMENTATION AND COMPARISON OF OTHER STATES’ AND COUNTRIES’ 
AID IN DYING LAWS 
In the United States, individual states can enact statutes to create 
an ability for physicians and patients to participate in aid in dying, but 
states may also explicitly ban any physician-assisted death without 
violating the Constitution.40  Even as applied to competent, terminally ill 
adult patients,41 the federal Constitution does not protect a patient’s 
access to aid in dying medication.42  In Washington v. Glucksberg, the 
 
 35 See id. 
 36 See id.  
 37 See id.  
 38 § 26:16-10(d). 
 39 N.J. STAT. ANN. § 26:16-13. 
 40 See Washington v. Glucksberg, 521 U.S. 702, 728, 735 (1997). 
 41 This is one of four scenarios where a person may wish to accelerate death.  The 
other three are suicide of a non-terminally ill person or patient, withdrawal of life 
support of a terminally ill patient, and physician active euthanasia of a terminally ill 
patient.  See NOAH R. FELDMAN & KATHLEEN M. SULLIVAN, CONSTITUTIONAL LAW 595 (20th ed. 
2019). 
 42 See Glucksberg, 521 U.S. at 735. 
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Supreme Court concluded that past precedent allowing patients to deny 
unwanted, life-sustaining treatment does not transform into a right to 
assisted suicide.43  Furthermore, it held that the right to personal 
autonomy under the Due Process Clause of the federal Constitution does 
not extend to every possible personal decision.44  This Part will compare 
the self-administration, residency, and time between request 
requirements in New Jersey to those requirements in other states and 
countries. 
A.  Definitional Comparisons of United States Statutes 
In Oregon, patients have access to medication to hasten death 
through the state’s Death with Dignity Act.45  In 1994, citizens voted in 
the act by a small margin, but then an injunction stalled the process until 
1997 when a second vote to keep the legislation resulted in the law’s 
enactment.46  Oregon Health Authority has been collecting data since 
that year.47  Oregon’s act does not provide specific language for a self-
administration requirement.48  It does, however, require a written 
request signed and dated by a qualified patient,49 which suggests a need 
for the patient to have a level of physical strength and control, similarly 
required for physical self-administration in New Jersey.50  The Oregon 
Health Authority does clarify that a patient must self-administer and 
that a physician may not administer.51  Oregon’s residency requirement 
provides a list of acceptable documentation, such as a driver’s license, 
voter registration, and tax return,52 but leaves discretion, like in New 
Jersey’s act, by allowing other documentation.  Additionally, the ability 
for a person to show he leases property as documentation53 may allow 
for a non-resident to meet this requirement.  Oregon required fifteen 
days between the first request and a prescription and 48 hours between 
 
 43 See id. at 725–26.  The Court references its discussion of removing treatment in 
Cruzan v. Director, Missouri. Dept. of Health, and of ending life in Vacco v. Quill.  Id. 
 44 See id. at 727–28.  The Court references its discussion of right to abortion in 
Planned Parenthood of Southeastern Pennsylvania v. Casey.  Id. 
 45 Frequently Asked Questions: Oregon’s Death with Dignity Act, OR. HEALTH AUTHORITY, 
https://www.oregon.gov/oha/PH/PROVIDERPARTNERRESOURCES/EVALUATIONRE
SEARCH/DEATHWITHDIGNITYACT/Pages/faqs.aspx (last visited Nov. 1, 2020). 
 46 Id. 
 47 See id.  
 48 OR. REV. STAT. §§ 127.800–127.897 (1994). 
 49 § 127.810-2.02. 
 50 See supra text accompanying note 23. 
 51 Frequently Asked Questions: Oregon’s Death with Dignity Act, supra note 45. 
 52 OR. REV. STAT. § 127.860-3.10. 
 53 Id.  
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a written request and prescription54 and, like New Jersey, did not set a 
maximum time period between requests.  But a change to Oregon law in 
2019 allowed Oregon patients to bypass the fifteen-day waiting period 
if they are expected to die within the fifteen days.55 
In California, qualified terminally ill patients can request aid in 
dying medication through the End of Life Option Act.56  California’s 
history in allowing aid in dying as an end of life option began, in part, 
with a patient named Brittany Maynard.57  At twenty-nine-years-old, 
Brittany was diagnosed with a brain tumor but with an otherwise 
healthy body and expected a lengthy, painful death.58  After doing some 
research about her treatment options, she chose to use aid in dying 
medication, but that option was unavailable in California.59  Brittany 
moved to Oregon, found new doctors, and established residency to 
qualify for Oregon’s act.60  She received the aid in dying medication in 
Oregon but kept fighting for a change in California’s law and end of life 
options.61 
Under the California act, an aid in dying drug is specifically defined 
as a drug an individual can self-administer,62 and “‘[s]elf-administer’ 
means a qualified individual’s affirmative, conscious, and physical act of 
administering and ingesting the aid-in-dying drug to bring about his or 
her own death.”63  California also explicitly requires that an individual 
must have the physical ability to self-administer,64 and reinforces these 
physical requirements by mandating (a) a request form signed and 
dated by the patient;65 and (b) a final attestation form signed, initialed, 
and dated by the patient 48 hours before the patient self-administers.66  
Notably, California’s act explicitly prohibits a person who is present at 
 
 54 § 127.850-3.08. 
 55 The Oregonian/OregonLive Politics Team, New Law Shortens ‘Death with Dignity’ 
Waiting Period for Some Patients, OREGONIAN (July 24, 2019), https://www.oregon
live.com/politics/2019/07/new-law-shortens-death-with-dignity-waiting-period-for-
some-patients.html. 
 56 End of Life Option Act, CAL. DEP’T PUB. HEALTH, https://www.cdph.ca.gov/
Programs/CHSI/Pages/End-of-Life-Option-Act-.aspx (last visited Nov. 1, 2020). 
 57 See Brittany Maynard, COMPASSION & CHOICES, https://compassionandchoices.org/
stories/brittany-maynard (last visited Nov. 1, 2020). 
 58 Id. 
 59 See id. 
 60 Id.  
 61 See id.  
 62 CAL. HEALTH & SAFETY CODE § 443.1 (West 2015). 
 63 Id.  
 64 § 443.2. 
 65 Id.  
 66 § 443.5, .11. 
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the time of death from helping a patient ingest the medication.67  Overall, 
California’s language and requirements surrounding self-
administration are more explicit than those in New Jersey’s act.  New 
Jersey lacks any language describing how a patient must ingest a 
medication and does not specifically reinforce the physical strength 
needed near the time of self-administration through a final attestation 
form, as California’s act does. 
Unlike New Jersey, California does not allow for any unlisted forms 
of identification to show residency.68  California’s requirement does, 
however, allow for a patient to demonstrate residency through a leased 
property,69 similar to Oregon’s residency requirement.70  California’s 
requirement of a minimum of fifteen days between requests, but no 
maximum number of days,71 parallels New Jersey’s requirement.72  
California does, however, add a maximum time of 48 hours for a patient 
to complete a final attestation form and self-administer the aid in dying 
drug.73  New Jersey’s law contains no similar temporal limitation. 
In Washington state, patients can access aid in dying medication 
through the Death with Dignity Act.74  The law was approved by voters 
in 2008 after a ballot initiative campaign launched in 2005 with the 
support of Oregon funds and advisers; then, it became effective in March 
2009.75  Washington’s act clarifies that self-administration must be 
through an act of ingesting medication.76  In Washington, a qualified 
patient must sign and date a written request;77 this suggests the same 
level of physical strength and ability to self-administer under the New 
Jersey act, which does not explicitly say that a patient must ingest aid in 
dying medication.  Washington’s residency requirement allows for 
unlisted documentation outside the options and allows for a patient to 
show leased property as evidence of residency.78  These broad options 
allow for more residency options than the acts in New Jersey, Oregon, 
 
 67 CAL. HEALTH & SAFETY CODE § 443.14. 
 68 § 443.2. 
 69 Id. 
 70 OR. REV. STAT. § 127.860-3.10. 
 71 CAL. HEALTH & SAFETY CODE § 443.3. 
 72 N.J. STAT. ANN. § 26:16-10. 
 73 CAL. HEALTH & SAFETY CODE § 443.5. 
 74 Death with Dignity Act, WASH. ST. DEP’T HEALTH, https://www.doh.wa.gov/Youand
YourFamily/IllnessandDisease/DeathwithDignityAct (last visited Oct. 31, 2019). 
 75 Washington, DEATH WITH DIGNITY, https://www.deathwithdignity.org/states/
washington (last visited Sept. 18, 2019).   
 76 WASH. REV. CODE § 70.245.010 (2008). 
 77 § 70.245.090. 
 78 § 70.245.130.  Options to show residency include a state driver’s license, voter 
registration, and owning or leasing property in the state.  Id. 
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and California.  The fifteen days required between oral requests and 48 
hours required from a physician receiving a written request and writing 
a prescription79 match New Jersey’s time between requests 
requirements.80 
In Colorado, terminally ill patients can access aid in dying 
medication pursuant to Colorado’s End-of-Life Options Act,81 which 
voters approved in 2016.82  Colorado requires a qualified patient to 
make an informed decision to self-administer.83  “‘Self-administer’ 
means a qualified individual’s affirmative, conscious, and physical act of 
administering the medical aid in dying medication to himself or herself 
to bring about his or her own death.”84  This language is similar to the 
California law but, like New Jersey’s statute, it fails to explicitly require 
that a patient ingest the medication.  Colorado also requires a patient to 
sign and date a written request,85 which, like New Jersey’s requirement, 
reinforces the requirement of the patient’s physical ability to self-
administer.  Unlike New Jersey, Colorado only allows for the listed 
documentation options to prove residency, but one of these options 
includes showing a leased property in the state.86  Colorado requires 
fifteen days between oral requests87 but, unlike New Jersey, does not 
add an additional forty-eight-hour waiting period between the patient 
making the written request and the physician writing the prescription. 
Patients in Maine recently gained access to aid in dying with 
Maine’s Death with Dignity Act.88  The state legislature voted in the act 
in Spring 2019, and Governor Janet Mills signed it into law in June 
2019.89  In Maine, a qualified patient may self-administer by “voluntarily 
ingest[ing] medication to end the qualified patient’s life in a humane and 
dignified manner.”90  This language differs from New Jersey’s approach 
by specifically requiring a patient to ingest the medication.  Like New 
Jersey and other states, the Maine act requires the patient to have the 
 
 79 § 70.245.090, .110. 
 80 N.J. STAT. ANN. § 26:16-10. 
 81 Medical Aid in Dying, COLO. DEP’T OF PUB. HEALTH & ENV’T, https://www.colorado.
gov/pacific/cdphe/medical-aid-dying (last visited Oct. 31, 2019). 
 82 Id. 
 83 COLO. REV. STAT. § 25-48-102 (2016). 
 84 Id. 
 85 § 25-48-104; see also § 25-48-112. 
 86 § 25-48-102. 
 87 § 25-48-104. 
 88 Paula Span, Aid in Dying Soon Will Be Available to More Americans. Few Will Choose 
It., N.Y. TIMES (July 8, 2019), https://www.nytimes.com/2019/07/08/health/aid-in-
dying-states.html.   
 89 Id. 
 90 ME. REV. STAT. ANN. tit. 418, § 2140(2)(L) (2019). 
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physical capacity to sign and date a written form.91  Maine’s residency 
requirement offers the longest list of options for documentation of 
residency and gives the most detail in what the documentation can and 
cannot show.92 
The residence of a person is that place where the person has 
established a fixed and principal home to which the person, 
whenever temporarily absent, intends to return. The following 
factors may be offered in determining a person’s residence 
under this Act and need not all be present in order to 
determine a person’s residence: A. Possession of a valid 
driver’s license issued by the Department of the Secretary of 
State, Bureau of Motor Vehicles; B. Registration to vote in this 
State; C. Evidence that the person owns or leases property in 
this State; D. The location of any dwelling currently occupied 
by the person; E. The place where any motor vehicle owned 
by the person is registered; F. The residence address, not a 
post office box, shown on a current income tax return; G. The 
residence address, not a post office box, at which the person’s 
mail is received; H. The residence address, not a post office box, 
shown on any current resident hunting or fishing licenses held 
by the person; I. The residence address, not a post office box, 
shown on any driver’s license held by the person; J. The receipt 
of any public benefit conditioned upon residency, defined 
substantially as provided in this subsection; or K. Any other 
objective facts tending to indicate a person’s place of 
residence.93 
Unlike other states, Maine’s other evidence option relies more on 
objective facts of residency than other forms of identification.  
Additionally, the “need not all be present” phrase can prompt physicians 
to consider multiple forms of identification, which other states, 
including New Jersey, have failed to recommend.94  While Maine’s 
residency requirements are unique, its waiting period requirements for 
a minimum of fifteen days between oral requests95 and 48 hours from a 
patient writing a request and the physician writing a prescription96 




 91 § 2140(5). 
 92 § 2140(15).  
 93 Id. (emphasis added). 
 94 N.J. STAT. ANN. § 26:16-11. 
 95 ME. REV. STAT. ANN. tit. § 2140(11) (2019). 
 96 § 2140(13). 
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B.  Aid in Dying Around the World: A Comparison of New Jersey and 
United States Requirements with International Requirements 
In Belgium, competent adults and emancipated minors gained 
access to hasten their death pursuant to The Belgian Act on Euthanasia 
on May 28, 2002.97  These persons must be patients “in a medically futile 
condition of constant and unbearable physical or mental suffering that 
can not [sic] be alleviated, resulting from a serious and incurable 
disorder caused by illness or accident.”98  In 2014, Belgium removed its 
previous age limit; thus, the country radically extended its law to allow 
children of any age to request the lethal injection as long as the parents 
give consent.99  Since then, physicians have euthanized seventeen-, 
eleven-, and nine-year-old patients.100  Rather than requiring patients to 
self-administer, Belgium allows euthanasia, which it defines as a 
physician—not the patient—terminating the patient’s life.101   
The default requirements under Belgian law do assume some level 
of patient physical strength and ability.  Similar to New Jersey and other 
United States acts, Belgium’s act requires a patient to write and sign a 
request.102  Unlike in New Jersey and the United States, however, 
Belgium provides an exception where a patient may designate a person 
to write and sign the request if the person lists why the patient is 
incapable of independently writing a request.103  Therefore, Belgium 
does not necessarily restrict patients who are physically disabled from 
their illness or a previous condition from access to euthanasia, whereas 
New Jersey and other states restrict these patients from access to aid in 
dying options.   
Additionally, Belgium’s act does not contain residency 
requirements.104  Further, Belgium’s equivalent of the time between 
requests requirements offers more discretion than New Jersey or other 
 
 97 Belgium, PATIENTS RTS. COUNCIL, http://www.patientsrightscouncil.org/site/
belgium (last visited Sept. 19, 2019). 
 98 § 1 [The Belgian Act on Euthanasia] of May 28, 2002, 10 EUR. J. HEALTH L. 329 
(2003). 
 99 Belgium, PATIENTS RTS. COUNCIL, http://www.patientsrightscouncil.org/site/
belgium (last visited Nov. 13, 2020).  Note that while technically the child makes the 
decision, it is easy to imagine the technical lines blurring between a child making a 
decision and a parent making a decision but a child expressing it as her own. 
 100 Dale Hurd, The ‘Default Way to Die’: Are Dutch and Belgian Doctors Euthanizing 
People Who Don’t Want to Die?, CHRISTIAN BROADCASTING NETWORK (Aug. 28, 2019), 
https://www1.cbn.com/cbnnews/world/2019/april/euthanasia-becoming-default-
way-to-die-in-belgium. 
 101 § 1 [The Belgian Act on Euthanasia] of May 28, 2002. 
 102 § 3(4) (Belg.). 
 103 Id. 
 104 See [The Belgian Act on Euthanasia] of May 28, 2002. 
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United States laws.  The act requires physicians to engage in “several” 
conversations with the patient about the patient’s request and physical 
and mental suffering over a “reasonable period of time.”105  Belgium’s 
act is clear, however, in requiring at least one month between the 
written request and euthanasia if the “physician believes patient is 
clearly not expected to die in the near future.”106  One month between a 
written request and death is longer than New Jersey’s 48 hours,107 but 
the above language leaves the physician some discretion and an ability 
to euthanize even before 48 hours have elapsed. 
Even though Belgium does not require a maximum time between 
requests and death, Belgium does cap advance directives for euthanasia; 
still, people who may not be mentally competent at the time of 
administration may access Belgium’s act.108  If the patient’s euthanasia 
request comes as an advance directive, the directive will only be valid if 
it was drafted in the last “five years prior to the person’s loss of the 
ability to express his/her wishes.”109   
In 2019, developments to Canada’s aid in dying law offered some 
compelling justifications for why a state or country should allow 
advance directives for medically assisted dying.110  Members of Canada’s 
legislative body recognize that Alzheimer’s patients are in a unique 
position: when they are first diagnosed, they may be able to consent to 
medical assistance in dying, but they are not at the required “end of 
life.”111  But, when an Alzheimer’s patient is near the end of life, they 
have lost their ability to make a decision about medical assistance in 
dying.112  This legislative debate follows the Lamb case, where the court 
expanded what it means for a patient’s death to be “reasonably 
 
 105 § 3(2) (Belg.). 
 106 § 3(3) (Belg.). 
 107 N.J. STAT. ANN. § 26:16-10. 
 108 § 4(1) (Belg.).  “[A]n advance directive, a legal document that goes into effect only 
if you are incapacitated and unable to speak for yourself. This could be the result of 
disease or severe injury—no matter how old you are. It helps others know what type of 
medical care you want.”  NAT’L INST. ON AGING, Advance Care Planning: Healthcare 
Directives, U.S. DEP’T HEALTH & HUM. SERVS., https://www.nia.nih.gov/health/advance-
care-planning-healthcare-directives#after (last visited Jan. 9, 2020). 
 109 § 4(1) (Belg.). 
 110 See Quebec to Expand Law on Medically Assisted Dying, Look at Advance Consent, 
CBC NEWS (Nov. 29, 2019 9:34 AM), https://www.cbc.ca/news/canada/montreal/
medical-assistance-in-death-report-1.5377890. 
 111 See id. 
 112 See id.  See infra pp. 870–72, for an explanation of why New Jersey should not use 
advance directives for aid in dying. 
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foreseeable.”113  The Supreme Court ruled against the current legislative 
members’ understandings of “reasonably foreseeable” and in favor of a 
patient-centered definition where “patients can meet the ‘reasonably 
foreseeable’ criterion if they have demonstrated a clear intent to take 
steps to make their natural death happen soon or to cause their death to 
be predictable.”114  The case could expand the current understanding of 
the legislation to allow for advance directives, which may not require 
informed consent at the time of request and the time of either 
euthanasia or self-administration.115  An advance directive could mean 
the patient has lost his capacity to make informed consent by the time 
he is requesting or receiving aid in dying treatment.  Canada already 
allowed patients with dementia, who still understand the requests they 
are making, to be capable of the required informed consent.116 
Since 2002, doctors in the Netherlands have been legally allowed 
to perform euthanasia on patients or assist in their suicides, even if the 
patients do not have a terminal illness.117  By 2015, 4.5% of deaths in the 
Netherlands were caused by acts of euthanasia, with non-terminally ill 
patients being a small portion of that percentage.118  In 2018, 
committees reviewed cases of euthanasia to compile resources and 
guidance for physicians in the Euthanasia Code 2018.119  In addition to 
the lack of minimum or maximum time required between requests and 
death,120 the Netherlands act is not concerned with a specific prognosis.  
It only requires that a patient’s suffering be “lasting and unbearable.”121 
 
 113 Jocelyn Downie, A Watershed Month for Medical Assistance in Dying, POL’Y OPTIONS 
POLITIQUES (Sept. 20, 2019), https://policyoptions.irpp.org/magazines/september-
2019/a-watershed-month-for-medical-assistance-in-dying. 
 114 See id. 
 115 See Medical Assistance in Dying, GOV’T OF CAN., https://www.canada.ca/en/health-
canada/services/medical-assistance-dying.html (last visited Feb. 14, 2020). 
 116 See, e.g., The Sunday Edition, B.C. Man Is One of the First Canadians With Dementia 
to Die with Medical Assistance, CBC RADIO (Oct. 27, 2019), https://www.cbc.ca/radio/
thesundayedition/the-sunday-edition-for-october-27-2019-1.5335017/b-c-man-is-
one-of-the-first-canadians-with-dementia-to-die-with-medical-assistance-1.5335025.  
 117 The Associated Press, Euthanasia Deaths Becoming Common in Netherlands, CBS 
NEWS (Aug. 3, 2017), https://www.cbsnews.com/news/euthanasia-assisted-suicide-
deaths-netherlands. 
 118 Id. 




 120 Termination of Life on Request and Assisted Suicide (Review Procedures) Act 
2001, 137. Art. 2(1)e (Neth.), https://www.worldrtd.net/dutch-law-termination-life-
request-and-assisted-suicide-complete-text.  
 121 See id. at Art. 2(1)b (Neth.). 
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Netherlands’ act does not contain language requiring a patient to 
administer his own medication.  Rather, in the Netherlands, doctors can 
give a lethal injection to a person with unbearable suffering and no 
reasonable alternative.122  In its first criminal investigation of 
euthanasia, the Netherlands court cleared a doctor of any criminal 
charges for administering a sedative and lethal injection to a dementia 
patient who exhibited mixed signals about wanting to die.123  The 
patient in this case, and like many other reported cases in the 
Netherlands, had an advanced directive for euthanasia, and the doctor 
had to perform that directive with due care.124   
At first glance, this case seems like the result of the “slippery slope” 
people might be wary of and that United States laws want to protect 
against by allowing only patients to self-administer their prescribed aid 
in dying medications.  But the doctor or the patient administering is not 
the only distinction in this case.  Even if states allowed for physician 
administration, patients and health care professionals would not face 
the issues seen in the Netherlands case.  In that case, the patient had an 
advance directive for euthanasia, like the law in Belgium allows and 
possible changes to the law in Canada would allow;125 no United States 
statute, however, allows advance directives for aid in dying medication.  
The Netherlands patient was not able to change her mind at the time of 
administration, and the doctor ignored her mixed signals because of her 
dementia.126   A New Jersey case would never reach this point—even if 
physicians could administer or prepare injections—because New Jersey 
further requires the qualified patient to be capable and “hav[e] the 
capacity to make health care decisions and to communicate them to a 
health care provider, including communication through persons 
familiar with the patient’s manner of communicating if those persons 
are available.”127  Given the symptoms of dementia,128 it does not seem 
 
 122 Palko Karasz, Dutch Court Clears Doctor in Euthanasia of Dementia Patient, N.Y. 
TIMES (Sept. 11, 2019), https://www.nytimes.com/2019/09/11/world/europe/
netherlands-euthanasia-doctor.html.  For more recent examples of Dutch courts 
allowing physicians to euthanize patients with dementia, see Another Netherlands Court 
Approves Euthanasia by Advance Directive, MED. FUTILITY BLOG (Sept. 14, 2020), 
http://www.bioethics.net/2020/09/another-netherlands-court-approves-euthanasia-
by-advance-directive. 
 123 See Karasz, supra note 122. 
 124 See id. 
 125 See supra pp. 857–59. 
 126 See Karasz, supra note 122. 
 127 N.J. STAT. ANN. § 26:16-3. 
 128 “Dementia is the loss of cognitive functioning—thinking, remembering, and 
reasoning—and behavioral abilities to such an extent that it interferes with a person’s 
daily life and activities. These functions include memory, language skills, visual 
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like many qualified terminally ill patients with dementia would be 
deemed capable to make this health care decision.129  Even if a physician 
found an otherwise qualified terminally ill patient with early-stage 
dementia capable under the New Jersey act, the patient would not have 
the ability to make an advance directive for when the dementia 
progresses and would always have the ability to rescind a request 
regardless of his patient’s previous wishes.130  New Jersey’s lack of a 
maximum time between requests would allow the patient to complete 
the request process very early in the stages of dementia, then, wait to 
take the medication. 
In Western Australia, patients gained access to aid in dying with the 
Voluntary Assisted Dying Bill.131  As the Victorian Voluntary Assisted 
Dying Act 2017 became effective in June 2019, another Australian state, 
Western Australia, was developing legislation in its parliament for its 
own Voluntary Assisted Dying Act.132  As Western Australia continued 
developing legislation, an Australian woman became the first to use 
Victoria’s new law.133  After a twenty-six-day approvals process, 
terminal cancer patient Kerry Robertson died at a nursing home.134   
Of all these international sources, Western Australia’s 
requirements and safeguards for administration of medication, 
residency, and timing of requests most closely parallel those used across 
the United States, so New Jersey could implement some of Western 
Australia’s safeguards.  Furthermore, Western Australia’s act allows 
United States health departments to draw more exact international 
comparisons about aid in dying and consider cross-cultural 
explanations for differences in trends.  It is more challenging to compare 
numbers across countries’ sets of data when the countries allow 
 
perception, problem solving, self-management, and the ability to focus and pay 
attention.”  Nat’l Inst. of Aging, What Is Dementia? Symptoms, Types, and Diagnosis, U.S. 
DEP’T HEALTH & HUM. SERVS., https://www.nia.nih.gov/health/what-dementia-
symptoms-types-and-diagnosis (last visited Jan. 9, 2020). 
 129 But see The Sunday Edition, supra note 116. 
 130 N.J. STAT. ANN. § 26:16-6(8). 
 131 See Voluntary Assisted Dying Bill 2019 (WA) (Austl.), https://www.parliament.wa.
gov.au/Parliament/Bills.nsf/502E87F2E1B94E27482584A3003A757C/$File/Bill139-
2.pdf; see also Voluntary Assisted Dying Bill 2019, PARLIAMENT W. AUSTL., 
https://www.parliament.wa.gov.au/parliament/bills.nsf/BillProgressPopup?openFor
m&ParentUNID=502E87F2E1B94E27482584A3003A757C (last visited Jan. 10, 2020). 
 132 Bregje Onwuteaka-Philipsen, Lindy Willmot & Ben P. White, Regulating Voluntary 
Assisted Dying in Australia: Some Insights from the Netherlands, MED. J. AUSTL. (Sept. 9, 
2019), https://www.mja.com.au/journal/2019/211/10/regulating-voluntary-
assisted-dying-australia-some-insights-netherlands#4.   
 133 Assisted Dying: Australian Cancer Patient First to Use New Law, BBC NEWS (Aug. 5, 
2019), https://www.bbc.com/news/world-australia-49230903. 
 134 Id. 
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patients of different ages and categories, such as minors or non-
terminally ill patients, to access aid in dying options.135 
Even though the Western Australian bill was modeled after the 
Victorian act, it differs in its definition of acceptable administration 
methods.136  In Western Australia, self-administration is the default 
option for a patient receiving medication.137  A patient with a six-month 
prognosis138 can make the decision to have her physician administer the 
substance if the physician has certain qualifications to be an 
administering practitioner, including specific training.139  A patient may 
choose to self-administer or to have the practitioner administer the 
medication.140  Patients have an equal ability to choose between 
practitioner administration or self-administration, but the provision 
requires that practitioner administration should only be used when it 
would be impossible or inappropriate for a patient to self-administer.141  
This language strikes a balance between (a) an emphasis on patients 
taking their own voluntary assisted death actions and (b) a conscious 
inclusion of patients who may lack physical ability but who are identical 
to other patients in every other requirement.  The signed, written 
declaration requirement142 suggests that patients using the law must 
have the physical ability to self-administer, as New Jersey’s act requires.  
But, as Belgium’s act requires,143 an Australian patient who is unable to 
sign the declaration can have another person sign the declaration on her 
 
 135 In other words, current cross-cultural comparisons are limited because of the 
certain requirements in other countries.  For example, if data trends showed patients in 
Belgium spending five years between request and administration and New Jersey 
patients show an average of six months between request and administration, it would 
be hard to infer that this has something to do with the culture of healthcare in either 
country because Belgium, unlike New Jersey, does not require a six-month prognosis but 
does allow advance directives.  A data analyst trying to infer cultural differences 
between any/all U.S. states and Western Australia could be more confident in that 
comparison because the similarities between the laws means eliminating differing 
requirements that would otherwise be intervening variables. 
 136 Frances Bell, Voluntary Euthanasia Bill to Be Introduced into West Australian 
Parliament, ABC NEWS (Aug. 6, 2019), https://www.abc.net.au/news/2019-08-06/
voluntary-assisted-dying-bill-introduced-to-wa-parliament/11386512. 
 137 Voluntary Assisted Dying Bill 2019 (WA) pt 4 div 2 s 56 (Austl.), 
https://www.parliament.wa.gov.au/Parliament/Bills.nsf/502E87F2E1B94E27482584
A3003A757C/$File/Bill139-2.pdf. 
 138 Id. pt 2 s 16.  But a twelve-month prognosis is required for neurodegenerative 
illness.  Id. 
 139 Id. pt 4 div 1 ss 54–55. 
 140 Id. s 56. 
 141 See id. 
 142 Voluntary Assisted Dying Bill 2019 (WA) pt 3 div 5 s 42. 
 143 § 3(4) [The Belgian Act on Euthanasia] of May 28, 2002. 
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behalf.144  The default option encourages a patient’s physical ability to 
self-administer, but the exception allows a patient with a physical 
disability from a previous condition or the terminal illness to still access 
voluntary assisted dying.  Physically disabled patients in New Jersey and 
across the United States, however, are not granted these exceptions for 
providing written documentation or for self-administration. 
Western Australia’s residency requirement is based on objective 
facts about residency in the prior year, rather than specific 
documentation.145  The most notable part of this requirement is the 
specific ability of a patient to appeal to the Western Australian residency 
decision from either the coordinating or consulting physician to a 
tribunal.146  New Jersey does not specifically allow for this type of 
external, non-medical professional appeals process.  Western Australia 
only requires nine days between the first and final request for voluntary 
assisted dying147 and allows for an exception to the minimum nine days 
if, among other requirements, the coordinating physician believes “the 
patient is likely to die, or to lose decision-making capacity in relation to 
voluntary assisted dying, before the end of the designated period.”148  
While New Jersey does not currently allow for physicians and patients 
to hasten this process, future amendments should mirror the exceptions 
in the Western Australian act and the amended Oregon act.149 
IV.  STATISTICAL COMPARISON OF NEW JERSEY AND OTHER STATES AND 
COUNTRIES 
This Part reviews aid in dying data from other states and countries 
discussed in this Comment, compares it with United States census data, 
and makes predictions about how providers and patients could use New 
Jersey’s act.  This Part also considers data-reporting concerns similar to 




 144 Id.  
 145 See id. pt 2 s 16. 
 146 Id. pt. 5 sec. 84. 
 147 Id. pt. 3 div. 6 sec. 47. 
 148 Id. pt. 3 div. 6 sec. 47. 
 149 See OregonLive Politics Team, supra note 55. 
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A.  Reported and Expected Deaths from Aid in Dying Medications150 
In Oregon’s data from 2017 through 2018, physicians wrote 467 
prescriptions for aid in dying medication, and within the two years, 311 
people died from ingesting the prescribed medication.151  United States 
census data for July 2017 through July 2018 revealed that 36,052 people 
died in Oregon that year,152 suggesting that 0.86% of deaths in Oregon 
could have resulted from aid in dying medication.   
California’s 2017–2018 data showed that physicians wrote 1,029 
prescriptions for aid in dying medication, and within that period, 711 
people died from the medication.153  Census data for July 2017 to July 
2018 revealed that 280,674 people died in the state that year,154 
suggesting that 0.25% of deaths in California could have resulted from 
aid in dying medication.   
Washington’s 2017–2018 data shows that physicians wrote 479 
prescriptions for aid in dying medication, and within the two years, 367 
people died from the medication.155  Census data for July 2017 to July 
 
 150 See infra App’x. at 874.  Note the lack of data for two other continental states that 
allow physician-assisted dying.  Montana’s Supreme Court ruled that Montana’s laws 
allow for physicians to provide medication to hasten patient death; thus, the state has 
not created an aid in dying statute with a reporting requirement and has not made data 
readily available.  See Baxter v. State, 224 P.3d 1211, 1222 (Mont. 2009); see also 
Montana, DEATH WITH DIGNITY, https://www.deathwithdignity.org/states/montana (last 
visited Jan. 5, 2020).  Vermont’s statute requires physicians to report writing 
prescriptions and death by aid in dying medication, but the state is only required to 
report every other year.  See Report Concerning Patient Choice at End of Life, VT. DEP’T 
HEALTH (Jan. 15, 2018), https://www.healthvermont.gov/systems/end-of-life-
decisions/patient-choice-and-control-end-life.  The initial and most recent report 
included years 2013–2017, so Vermont’s available data is not comparable to the other 
states’ 2017–2018 data.  See id. 
 151 Death with Dignity Act Annual Reports, OR. HEALTH AUTHORITY, 
https://www.oregon.gov/oha/ph/providerpartnerresources/evaluationresearch/dea
thwithdignityact/pages/ar-index.aspx (Year 2018) (last visited Sept. 20, 2019). 
 152 2018 National State and Population Estimates: Table 5. Estimates of the 
Components of Resident Population Change for the United States, Regions, States, and 
Puerto Rico: July 1, 2017 to July 1, 2018, U.S. CENSUS BUREAU, https://www.census.gov/
newsroom/press-kits/2018/pop-estimates-national-state.html (last visited Sept. 20, 
2019) [hereinafter 2018 National State and Population Estimates].  Note that available 
census data to track vital life events are measured from July 2017 through July 2018, 
while the states produce annual aid in dying reports on the calendar year.  Id.  This 
means, for example, a death in Colorado in June 2017 would be reflected in Colorado’s 
data, but not in the census for July 2017–July 2018.   
 153 End of Life Option Act 2018 Data Report, CAL. DEP’T PUB. HEALTH, at 3, 
https://www.cdph.ca.gov/Programs/CHSI/Pages/End-of-Life-Option-Act-.aspx (last 
visited Sept. 20, 2019).  Note that the two most common prescriptions were for 
sedatives and “a combination of a cardiotonic, opioid, and sedative.”  Id. at 3. 
 154 See 2018 National State and Population Estimates, supra note 152. 
 155 2018 Death with Dignity Act Report, WASH. ST. DEP’T HEALTH, at 1, 
https://www.doh.wa.gov/Portals/1/Documents/Pubs/422-109-DeathWithDignityAct
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2018 revealed that 57,568 people died in the state that year,156 
suggesting that 0.25% of deaths in Washington could have resulted from 
aid in dying medication.   
In its first two years of implementing its act, Colorado collected 
data showing that physicians wrote 197 prescriptions for aid in dying 
medication and that between 2017 and 2018, 174 people died from 
ingestion.157  Census data for July 2017 to July 2018 revealed that 38,367 
people died in the state that year,158 suggesting that 0.45% of deaths in 
Colorado could have resulted from aid in dying medication. 
B.  Data-Reporting Concerns and Predictions 
The lack of a maximum time between requests contributes to a 
data-reporting issue.  Current reports do not measure the time a patient 
spends in the initial stages of the aid in dying process.159  A future 
evaluation of the efficacy of the Act would benefit from understanding 
how long patients take to complete a decision.  The prescription-to-
administration-and-death timeline is only measured by the calendar 
year in current reports.160  The states’ data referenced above measures 
when a patient received a prescription in one year but ingested the 
medication in another year,161 but the reports cannot show whether 
these dates happen quickly between December and January of two 
calendar years or if patients tend to hold medication for many months 
or even a full year before self-administering.  New Jersey’s future data, 
if it only follows its current reporting requirements,162 will also fail to 
measure these points and track these issues. 
 
2018.pdf (last visited Sept. 20, 2019); 2017 Death with Dignity Act Report, WASH. ST. DEP’T 
HEALTH, at 1, https://www.doh.wa.gov/Portals/1/Documents/Pubs/422-109-Death
WithDignityAct2017.pdf (last visited Sept. 20, 2019). 
 156 See 2018 National State and Population Estimates, supra note 152. 
 157 Colorado End-of-Life Options Act, Year Two 2018 Data Summary, with Updates to 
2017 Data, COLO. DEP’T PUB. HEALTH & ENV’T, at 2, https://drive.google.com/file/d/
1FmoyCcL2gHopDO9rCJ2lGFEMUye8FQei/view (last visited Sept. 20, 2019).  Some 
individual state data, such as Colorado’s data, indicates the patient’s terminal illness.  See 
id.  Looking at this available data and discussing the physical symptoms of different 
illnesses might provide insight on the different capabilities of patients to self-
administer. 
 158 See 2018 National State and Population Estimates, supra note 152. 
 159 See sources cited supra notes 151–157. 
 160 See sources cited supra notes 151–157. 
 161 See sources cited supra notes 151–157. 
 162 The New Jersey statute includes the following reporting requirements: 
(1) No later than 30 days after the dispensing of medication pursuant 
to P.L.2019, c.59 (C.26:16-1 et al.), the physician or pharmacist who 
dispensed the medication shall file a copy of the dispensing record 
with the department, and shall otherwise facilitate the collection of 
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Despite these omissions of potentially useful data, this Comment 
purports to make predictive calculations for New Jersey’s use of aid in 
dying.  These predictions are simply rough calculations to raise 
potential concerns, address typical questions around aid in dying, and 
encourage facilities and physicians to further prepare for the Act in New 
Jersey.  The average of the above states’ percentages of death from 
ingesting prescribed medication is approximately 0.55% of state deaths.  
The average lies closest to Colorado’s 0.45%, which reflects a 
percentage of deaths in a state that has only had an aid in dying option 
for a few years.  By taking the 0.55% average and multiplying by the 
number of Maine deaths from July 2017 to July 2018 (14,079 deaths),163 
we can predict 77 deaths in Maine from ingesting prescribed 
medication.  By multiplying the same 0.55% average by New Jersey’s 
total deaths from July 2017 to July 2018 (76,370),164 we can estimate 
about 420 deaths within two years.165 
The average number of prescriptions within the past two years in 
Oregon, California, Washington, and Colorado is 543 prescriptions.  The 
average of the confirmed deaths from ingesting prescribed medication 
is 390.75 deaths.  Comparing the 543 prescriptions to the 390.75 deaths, 
there is an average proportion of 1.4 aid in dying prescriptions per 
death from ingesting the medication.  Applying this proportion to Maine 
suggests 107.8 prescriptions within two years.  Applying it to New 
Jersey suggests 588 prescriptions within two years.  These predictions 
would be even higher than the values for the past two years in 




such information as the director may require regarding compliance 
with P.L.2019, c.59 (C.26:16-1 et al.). 
(2) No later than 30 days after the date of the qualified terminally ill 
patient’s death, the attending physician shall transmit to the 
department such documentation of the patient’s death as the director 
shall require. 
N.J. STAT. ANN. § 26:16-13. 
 163 See 2018 National State and Population Estimates, supra note 152. 
 164 See id. 
 165 On July 31, 2020, approximately a year after enactment, New Jersey’s Department 
of Health released its first annual report.  Annual Report Chronicles Impact of New Jersey’s 
Death with Dignity Law, N.J. DEP’T OF HEALTH (July 31, 2020) [hereinafter Annual Report], 
https://www.nj.gov/health/news/2020/approved/20200731b.shtml.  While only 
twelve reported deaths, the state only released from between August 1, 2019 and 
December 31, 2019.  Id.  The release offers no explanation for the lack of reports between 
January 1, 2020 and July 30, 2020.  Id. 
 166 See supra note 151 and accompanying text. 
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These numbers do not, however, support any slippery slope 
argument about people choosing to end their lives in New Jersey more 
than in other states.167  Furthermore, these elementary predictions are 
simply meant to alert physicians and facilities that, insofar as New 
Jersey is similar to other states and has a similar statute, patients may 
use the Act similarly.  At an estimated 588 prescriptions per 
approximately two years, participating physicians across the state could 
be writing approximately one prescription every other day.  This 
potential level of use supports the concerns in the discussion below 
about considerations for changing residency and implementation to 
avoid errors in physician discretion and use of the Act.  These statutes 
are as much about patient choice as they are about compliance and the 
ability to report compliance with the definitions discussed above. 
C.  New Jersey Residency 
While not explicitly stated in New Jersey’s act, it is important to 
consider how New Jersey patients, physicians, and caretakers might lose 
protection under the Act if a patient self-administers in another state.168  
This is an especially important consideration for people who qualify as 
New Jersey residents because other states—New York and 
Pennsylvania, namely—are in such close proximity but do not offer any 
protections for medical aid in dying.  Depending upon physical ability 
and the type of illness, any transportation at the ultimate stage of an 
illness may become impossible, but the self-administration and writing 
requirements169 in New Jersey do require some level of physical 
strength that might make traveling with a terminal illness more 
probable.  While not the focus of this Comment, it is important to 
mention that a patient’s ability to move and take a drug elsewhere 
would create inaccuracies in how many people died in any given year in 
a state from self-administering medication and could distort results in 
reporting data as required by many of these statutes. 
 
 167 New Jersey just has more people, and more people could lead to a higher 
number—but there is no need for concern.  As a potential counter to any slippery slope 
concerns about New Jersey’s trends: if New Jersey followed the Netherlands trend of 
4.5% of deaths from euthanasia, it would be estimating about 3,437 deaths, a number 
more than eight times greater than the 420 deaths predicted based off of United States 
trends.  In fact, in the first six months, New Jersey only recorded twelve deaths.  See 
Annual Report, supra note 165. 
 168 “ If you take a dose prescribed under a death with dignity law outside the state 
where you obtained it, you may lose the legal protections afforded by the law in 
question. For example, your death may be ruled a suicide under another state’s law, with 
resulting effects on your insurance policies.”  Frequently Asked Questions, DEATH WITH 
DIGNITY, https://www.deathwithdignity.org/faqs (last visited Sept. 18, 2019). 
 169 See discussion supra Section II.B. 
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V.  RECOMMENDATIONS FOR NEW JERSEY 
This Part will recommend best practices for New Jersey facilities, 
including private practices or hospitals, under the current Act.  Then, it 
will offer some recommendations for amendments to the Act.   
A.  Implementation and Best Practices Under the Current Act 
New Jersey facilities have to be careful not to unfairly limit a 
patient’s ability to access the Act, but they can implement the internal 
safeguards below without changing the procedures outlined in the Act.  
Facilities have an interest in protecting their physicians and treating 
their patients with respect, whether or not their physicians are willing 
and able to aid in a patient’s death under the Act. 
1.  Provide Training for Self-administration 
Similar to how Western Australia requires all physicians to learn 
how to administer,170 New Jersey facilities or medical and hospital 
associations could provide training that teaches physicians how to teach 
patients to self-administer properly.  By enabling physicians to show 
patients and families how to properly self-administer, New Jersey might 
increase access to the Act for patients with certain physical disabilities 
who may think they are incapable of using the Act.  This training could 
also show physicians how to teach caretakers to prepare drugs for a 
patient’s self-administration.  If New Jersey wants to follow other states 
in requiring that the drugs be ingested rather than self-injected, the 
training would have to differentiate between those two forms of 
administration.  This would help enforce that patients should be 
ingesting medication, without explicitly changing the language of the 
Act.  Below, this Comment discusses the possibility of clarifying the Act 
to include both forms of administration explicitly, therefore, expanding 
the training possibilities.  Lastly, providing physician training could 
become a method for facilities and patients to determine which 
physicians may be willing and able to participate in the aid in dying 
process. 
2.  Documentation of Residency 
Facilities should consider providing an internal system that allows 
physicians to confirm a patient’s residency with a central residency 
point-person.  Similar to the tribunal appeal system required in Western 
Australia, under the proposed system, a patient could ask for 
reconsideration of a residency decision.  Before the initial decision or at 
 
 170 See supra note 139 and accompanying text. 
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the time of reconsideration, a physician and patient could refer to a 
point-person in a facility’s legal department or a resource at a state-wide 
medical or hospital association.  While New Jersey’s act explicitly states 
that the physician has discretion to accept another government 
document as confirmation of residency,171 there is nothing in the Act to 
prevent a physician from consulting with other professionals about 
whether the patient meets the residency requirement.  The point-
person could have a list of other documents, such as a lease in the state, 
or an understanding of a patient’s permanency or intent to return 
(similar to Maine’s residency requirements)172 to help a physician 
consider a patient’s residency.  The point-person could thoroughly 
consider what, if any, properties, licenses, or leases a patient has in other 
states that may determine whether a patient intends to stay in New 
Jersey or return to another state or country.   
A system for confirming residency would address some current 
implementation issues that result from requiring medical professionals 
to make determinations of residency.  Such a system would protect 
physicians from falsely identifying a patient as a resident through any of 
the documentation.  The system would also protect patients by making 
sure that they are not prohibited from using the Act simply because one 
physician did not determine residency under New Jersey’s requirement.  
While there may be instances where a physician determines that a 
person, such as an undocumented person, has enough “other 
documentation” to show residency, but the point-person disagrees, 
there could also be the inverse scenario where a physician does not find 
enough documentation, but the point-person does and increases access 
to the Act. 
Facilities should additionally consider including residency 
documentation within their data collection.  Without including the 
patient’s actual residency information, a facility could keep a record of 
which type of documentation was provided to determine residency and 
whether the facility found the patient to be a resident.  If a facility, 
through internal documents or state reports, finds that the unlisted 
options available are being used frequently, this may be a warning that 
non-New Jersey residents are crossing local state borders to access the 
Act. 
 
 171 N.J. STAT. ANN. § 26:16-11. 
 172 ME. REV. STAT. ANN. tit. 418, § 2140(15) (2019). 
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3.  Limiting Time Between Requests 
New Jersey only requires a minimum waiting period between 
requests.  Patients can wait more than fifteen days to make a second 
request and can wait after two oral requests to make a written 
request;173 the law does not, however, prevent a physician from 
continually clarifying that a patient is voluntarily requesting the 
medication.  Unlike other statutes, New Jersey physicians do not need to 
prepare final request forms under the Act.  Facilities could require 
professionals participating in the Act to use similar forms to indicate the 
physician’s own opinion at the time of prescription, even if an initial 
determination of eligibility was made months or years earlier.  This 
Comment does not suggest that facilities require patients to make more 
than the required number of requests, but rather that facilities supply a 
tool for physicians to review the patient’s eligibility if the requests are 
spread over time.  New Jersey’s Department of Health website currently 
provides a follow-up form, but it is only to confirm that the physician 
followed the Act’s requirements.174  A facility or physician’s practice 
should have its own form, similar to the final attestation form in 
California,175 that notes a patient’s mental health and physical capacity 
at the time the final request is made and confirms that the physician 
informed the patient of the facility’s ingestion recommendation and 
procedures.  
4.  Implementing Reporting Requirements 
In teaching New Jersey health care professionals about the Act and 
how to implement it effectively, it is important to recognize that, like 
many other statutes, New Jersey’s act has reporting requirements.176  
Even though reporting is already required, implementation efforts for 
the above definitions should continually emphasize the importance of 
accurate reporting.  Accurate reporting in patient medical records could 
prevent medical errors that could be irreversible in an aid in dying 
case.177  Physicians do not want to expose themselves to criminal 
liability for following the Act but failing to report, just as they want to 
 
 173 N.J. STAT. ANN. § 26:16-10. 
 174 Medical Aid in Dying, N.J. DEP’T HEALTH, https://www.state.nj.us/health/advance
directive/maid/#3 (last visited Jan. 10, 2020). 
 175 See supra note 73 and accompanying text. 
 176 Span, supra note 88.   
 177 See generally Christina Farr, This Patient’s Medical Record Said She’d Given Birth 
Twice – In Fact, She’d Never Been Pregnant, CNBC (last updated Dec. 9, 2018 8:25 PM), 
https://www.cnbc.com/2018/12/09/medical-record-errors-common-hard-to-
fix.html (discussing the national issue with minor medical reporting errors, including 
mistaken patient identity, leading to major problems). 
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avoid any medical reporting error that could put a lethal prescription in 
the wrong hands.178 
B.  Changes to the Act 
1.  Medication Administration 
New Jersey should consider explicitly allowing self-injection as a 
form of administration to increase access to the Act for people with 
existing or developed physical disabilities who cannot self-administer 
through ingesting a prepared regimen of aid in dying medication.  To 
complement this expansion of the Act to people with physical 
disabilities, New Jersey also needs an exception to the rule that the 
written request be executed solely by the patient.  To further implement 
these expansions, New Jersey might have to allow for a non-verbal form 
of communication typical of the patient, so the patient could convey his 
aid in dying wish without saying, “I would like aid in dying medication.”  
This might be a loved one conveying the patient’s interest and the 
patient showing or making a sound typical of that patient’s agreement 
to confirm the desire to make the request.179  This change, however, 
would need close monitoring.  While other states’ data has shown few 
instances of coercion and abuse,180 states have not allowed non-verbal 
requests; thus, New Jersey would need to report how the request was 
made to determine if non-verbal requests are correlated with higher 
instances of coercion and abuse. 
Even if New Jersey allows an injected form of self-administration, 
it would still have safeguards and restrictions, such as age, residency, 
and terminal illness requirements, which prevent access by certain 
patients.  Even if New Jersey extended past any other state to allow 
physician administration, New Jersey would not follow international 
trends.  New Jersey does not allow for advance directives for aid in 
dying, so the patient would be able to stop the treatment up until the 
moment of administration.   
 
 
 178 For more examples of implementation techniques, see The N.J. Aid in Dying for the 
Terminally Ill Implementation Toolkit, N.J. HOSP. ASS’N, http://www.njha.com/resources/
toolkits/the-nj-aid-in-dying-for-the-terminally-ill-implementation-toolkit (last visited 
Feb. 14, 2020). 
 179 I recognize the slippery slope concerns about coercion and elder abuse, but data 
from other states have not supported these arguments.  If New Jersey follows similar 
trends for patients who use the Act, the state can avoid these arguments and make 
changes to its Act. 
 180 See sources cited supra notes 151–157. 
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New Jersey could decrease potential use by further changing the 
law by adjusting the “age” requirement to consider more than just an 
individual’s stated age.  New Jersey could require more than just an 
arbitrary eighteen-year-old age requirement and look into the actual 
brain development of the individual to determine that individual’s 
mental capacity for making such a major, and permanent, health care 
decision.  This suggestion comes from recent developments in 
neuroscience, showing that most people do not have fully developed 
frontal lobes—the area of the brain used for decision-making—until 
their mid-twenties.181  This practical change to the law would include a 
requirement, similar to the requirement for checking general mental 
health capacity,182 that a physician sends patients aged 18 to 25 to 
mental health professionals.  The mental health professional would 
consider symptoms and brain scans of the patient’s frontal lobe, then 
determine if the patient is capable of adult-like decision-making. 
2.  Minimum Time Between Requests  
Like Oregon,183 New Jersey could amend its law to include an 
exception to the fifteen-day and forty-eight-hour waiting periods 
between requests and prescriptions.  While the current waiting period 
is important for encouraging patients to consider their decisions and 
consult family and mental health resources, it may be too arbitrary.  New 
Jersey should leave timing questions to the doctors who know whether 
a patient may die painfully between requests or lose the ability to 
complete the requests.   
VI.  CONCLUSION 
This Comment compared definitions and use across the United 
States and the world to raise some potential concerns for New Jersey 
facilities and physicians as they continue to choose whether to 
participate in New Jersey’s Medical Aid in Dying for the Terminally Ill 
Act.  This Comment identified trends that New Jersey might follow and 
 
 181 See NELL BERNSTEIN, BURNING DOWN THE HOUSE 207–09 (2014) (explaining recent 
studies and their subsequent influence on understanding the risks of incarcerating 
juvenile offenders in adult prisons); see also Neurolaw and Order, BBC NEWS (Dec. 6, 
2017), https://www.bbc.co.uk/programmes/w3cswcll.  for a recent argument in favor 
of halting the execution of a man who committed murder at age nineteen but was tried 
and sentenced to death before current developments in neuroimaging and studies of 
adolescent brains, see Dr. Jason Chein, Insight: Adolescent Brain Immaturity Makes 
Pending Execution Inappropriate, TEMPLE. UNIV. (Sept. 17, 2020 4:00 AM), 
https://news.bloomberglaw.com/coronavirus/insight-adolescent-brain-immaturity-
makes-pending-execution-inappropriate. 
 182 N.J. STAT. ANN. § 26:16-8. 
 183 See OregonLive Politics Team, supra note 55. 
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potential concerns of those trends.  This Comment recommended self-
administration training, utilization of residency experts, additional 
public reporting, and use of final report forms where no time limit 
between requests exists.  Additionally, this Comment suggested New 
Jersey amend its law to include both ingestion and injection 
administration, a less arbitrary age requirement, and exceptions to 
waiting periods.  This Comment encourages New Jersey facilities to use 
such recommendations and to be on alert to how future states and 
countries create aid in dying laws and address these issues.  New Jersey 
should consider its data over the next several years to re-evaluate the 
Act and consider whether making the above amendments would be 
appropriate given those results. 
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2017 & 2018 
Death by Aid 
in Dying 
Medication in 







Aid in Dying 
Medication 
OR 467 311 36,052 0.86% 
CA 1029 711 280,674 0.25% 
WA 479 367 57,568 0.25% 
CO 197 174 38,367 0.45% 
ME   14,079  




 184 This Table displays the numbers discussed in the text accompanying 
notes 150–165. 
